RCE Recce Signs Debt Facility with Avenue Capital Group 17/06/25 PRICE SENSITIVE download Created with Sketch. 310.22KB Share RCE Successful Placement of Entitlement Offer Shortfall 03/06/25 PRICE SENSITIVE download Created with Sketch. 254.46KB Share RCE China Patent Accepted for RECCE Anti-Infectives 26/05/25 PRICE SENSITIVE download Created with Sketch. 247.16KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 30/04/25 PRICE SENSITIVE download Created with Sketch. 375.03KB Share RCE Recce Enters into USA Department of Defense R&D Agreement 28/04/25 PRICE SENSITIVE download Created with Sketch. 326.72KB Share RCE Entitlement Offer - Offer Booklet and Access Letter 22/04/25 PRICE SENSITIVE download Created with Sketch. 990.5KB Share RCE Phase II Clinical Trial Receives Additional Approval for DFI 22/04/25 PRICE SENSITIVE download Created with Sketch. 220.81KB Share RCE Placement and Entitlement Offer to Fund Phase III Trials 10/04/25 PRICE SENSITIVE download Created with Sketch. 247.13KB Share RCE Key Opinion Leader Presentation 03/03/25 PRICE SENSITIVE download Created with Sketch. 3.75MB Share RCE Appendix 4D and Interim Financial Report 28/02/25 PRICE SENSITIVE download Created with Sketch. 734.76KB Share RCE Japan Patent Allowance for RECCE Anti-Infectives 26/02/25 PRICE SENSITIVE download Created with Sketch. 284.64KB Share RCE Positive Phase II Data from Clinical Trial of R327 Gel 17/02/25 PRICE SENSITIVE download Created with Sketch. 265.3KB Share RCE Trading Halt 13/02/25 PRICE SENSITIVE download Created with Sketch. 240.14KB Share RCE Pause in Trading 13/02/25 PRICE SENSITIVE download Created with Sketch. 115.54KB Share RCE Correction to Appendix 4C and Quarterly Activities Report 06/02/25 PRICE SENSITIVE download Created with Sketch. 370.23KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 31/01/25 PRICE SENSITIVE download Created with Sketch. 367.68KB Share RCE Patient Dosing Complete in Phase II ABSSSI Trial of R327G 21/01/25 PRICE SENSITIVE download Created with Sketch. 286.92KB Share RCE Regulatory Approval for Registrational Phase 3 R327G Trial 09/12/24 PRICE SENSITIVE download Created with Sketch. 265.32KB Share RCE Trading Halt 05/12/24 PRICE SENSITIVE download Created with Sketch. 567.51KB Share RCE Australia Patent Granted for RECCE Anti-Infectives 26/11/24 PRICE SENSITIVE download Created with Sketch. 213.38KB Share RCE AUD $6.75m R&D Rebate Approved 14/11/24 PRICE SENSITIVE download Created with Sketch. 208.49KB Share RCE Ethics Approval for Registrational Ph3 R327G Clinical Trial 11/11/24 PRICE SENSITIVE download Created with Sketch. 292.32KB Share RCE AGM Presentation 06/11/24 PRICE SENSITIVE download Created with Sketch. 1.1MB Share RCE Phase II ABSSSI Clinical Trial Advances to Final Stages 05/11/24 PRICE SENSITIVE download Created with Sketch. 303.63KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 31/10/24 PRICE SENSITIVE download Created with Sketch. 922.43KB Share RCE Efficacy Data & Approval to Continue Ph II ABSSSI Trial 28/10/24 PRICE SENSITIVE download Created with Sketch. 279.9KB Share RCE Ph II ABSSSI Trial Recruitment and Dosing Passes Halfway 09/10/24 PRICE SENSITIVE download Created with Sketch. 263.73KB Share RCE Notice of Special General Meeting/Proxy Form 08/10/24 PRICE SENSITIVE download Created with Sketch. 586.49KB Share RCE Preliminary Final Report 30/08/24 PRICE SENSITIVE download Created with Sketch. 126.72KB Share RCE Successful Completion of Share Purchase Plan 05/08/24 PRICE SENSITIVE download Created with Sketch. 242.48KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 26/07/24 PRICE SENSITIVE download Created with Sketch. 926.64KB Share RCE US Department of Defense Grants US $2m for R327G 15/07/24 PRICE SENSITIVE download Created with Sketch. 346.08KB Share RCE R327 Efficacy against WHO Priority Pathogen Acinetobacter B 08/07/24 PRICE SENSITIVE download Created with Sketch. 504.85KB Share RCE Placement & SPP to raise $10 million - Funded to FY26 02/07/24 PRICE SENSITIVE download Created with Sketch. 299.88KB Share RCE Trading Halt 01/07/24 PRICE SENSITIVE download Created with Sketch. 565.47KB Share RCE Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete 28/06/24 PRICE SENSITIVE download Created with Sketch. 381.7KB Share RCE Ethics Approval Broadens to All Topical Infections 24/06/24 PRICE SENSITIVE download Created with Sketch. 345.82KB Share RCE Further R&D Rebate Approved 18/06/24 PRICE SENSITIVE download Created with Sketch. 224.3KB Share RCE R327 added to WHO List of Antibacterial Products 18/06/24 PRICE SENSITIVE download Created with Sketch. 565.63KB Share RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial 11/06/24 PRICE SENSITIVE download Created with Sketch. 262.74KB Share RCE Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort 15/05/24 PRICE SENSITIVE download Created with Sketch. 239.86KB Share RCE MCRI Pilot Study- Positive Efficacy Data for Lung Infections 09/05/24 PRICE SENSITIVE download Created with Sketch. 498KB Share RCE China Patent Granted for RECCE Anti-Infectives 07/05/24 PRICE SENSITIVE download Created with Sketch. 241.55KB Share RCE Safety Committee Approves High Dose of 4,000mg 26/04/24 PRICE SENSITIVE download Created with Sketch. 263.52KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 22/04/24 PRICE SENSITIVE download Created with Sketch. 575.83KB Share RCE Recce Completes 5,000 R327 Doses Per Week under GMP 16/04/24 PRICE SENSITIVE download Created with Sketch. 217.27KB Share RCE Recce Pharmaceuticals - Business Update 08/04/24 PRICE SENSITIVE download Created with Sketch. 582.67KB Share RCE Patent Granted in Israel for RECCE Anti-Infectives 03/04/24 PRICE SENSITIVE download Created with Sketch. 324.65KB Share RCE Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial 15/03/24 PRICE SENSITIVE download Created with Sketch. 278.98KB Share RCE Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial 12/03/24 PRICE SENSITIVE download Created with Sketch. 262.97KB Share RCE Recce Receives AUD $11.17m R&D Advance 08/03/24 PRICE SENSITIVE download Created with Sketch. 238.07KB Share RCE Appendix 4D and Interim Financial Report 27/02/24 PRICE SENSITIVE download Created with Sketch. 464.55KB Share RCE Safety Committee Approves Expansion of Ph I/II DFI Trial 26/02/24 PRICE SENSITIVE download Created with Sketch. 246.18KB Share RCE RCE Establishes Strategic Partnership in South-East Asia 06/02/24 PRICE SENSITIVE download Created with Sketch. 451.89KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 30/01/24 PRICE SENSITIVE download Created with Sketch. 746.24KB Share RCE Positive Ph I/II DFI Efficacy Data to Support Site Expansion 18/01/24 PRICE SENSITIVE download Created with Sketch. 266.33KB Share RCE Murdoch Children's R327 Efficacy UTI in-vivo 28/12/23 PRICE SENSITIVE download Created with Sketch. 384.21KB Share RCE RCE Awarded Further $11.17m Advanced Overseas Finding 15/12/23 PRICE SENSITIVE download Created with Sketch. 382.33KB Share RCE RCE Awarded $43.7m AusIndustry Advanced Overseas Finding 14/12/23 PRICE SENSITIVE download Created with Sketch. 376.84KB Share RCE Murdoch Children's R327 Efficacy N.gonorrhoeae in-vivo 14/12/23 PRICE SENSITIVE download Created with Sketch. 375.27KB Share RCE Canadian Patent Granted for RECCE Anti-Infectives 23/11/23 PRICE SENSITIVE download Created with Sketch. 320.09KB Share RCE Subjects Dosed Over 15 mins in UTI/Urosepsis Clinical Trial 07/11/23 PRICE SENSITIVE download Created with Sketch. 230.98KB Share RCE Committee Approves Fast 15-Min Infusion in Ph I/II Urosepsis 24/10/23 PRICE SENSITIVE download Created with Sketch. 305.03KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 20/10/23 PRICE SENSITIVE download Created with Sketch. 1.02MB Share RCE Completes Cohort Dosing UTI/Urosepsis Rapid Infusion Trial 22/09/23 PRICE SENSITIVE download Created with Sketch. 268.92KB Share RCE Placement and Entitlement Offer 11/09/23 PRICE SENSITIVE download Created with Sketch. 276.98KB Share RCE Trading Halt 08/09/23 PRICE SENSITIVE download Created with Sketch. 317.42KB Share RCE Opening R&D Address at World AMR Congress 08/09/23 PRICE SENSITIVE download Created with Sketch. 3.23MB Share RCE RECCE Trademark Registered - Vietnam 06/09/23 PRICE SENSITIVE download Created with Sketch. 289.61KB Share RCE Additional Positive Patient Cases - Special Access Scheme 31/08/23 PRICE SENSITIVE download Created with Sketch. 497.11KB Share RCE Appendix 4E and Unaudited Preliminary Report 31/08/23 PRICE SENSITIVE download Created with Sketch. 503.53KB Share RCE Next Dose Cleared in Rapid Infusion Phase I/II UTI Trial 28/08/23 PRICE SENSITIVE download Created with Sketch. 256.66KB Share RCE Patients Dosed in R327 Diabetic Foot Infection Trial 22/08/23 PRICE SENSITIVE download Created with Sketch. 281.98KB Share RCE Phase I/II Burn Wound Infection Trial Stage 1 Complete 21/08/23 PRICE SENSITIVE download Created with Sketch. 349.53KB Share RCE Positive Patients Update - Special Access Scheme 08/08/23 PRICE SENSITIVE download Created with Sketch. 537.59KB Share RCE Australian Patent Granted for RECCE Anti-Infectives 03/08/23 PRICE SENSITIVE download Created with Sketch. 318.83KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 31/07/23 PRICE SENSITIVE download Created with Sketch. 480.05KB Share RCE Bonus Canadian R&D Rebate Received 28/07/23 PRICE SENSITIVE download Created with Sketch. 265.44KB Share RCE Scientia Completes Cohort Dosing in Phase I/II UTI Trial 28/07/23 PRICE SENSITIVE download Created with Sketch. 273.47KB Share RCE Scientia Doses Ahead of Schedule in Phase I/II UTI Trial 24/07/23 PRICE SENSITIVE download Created with Sketch. 273.72KB Share RCE Clarification - 5x Higher Concentration in Urine & Plasma 20/07/23 PRICE SENSITIVE download Created with Sketch. 168.73KB Share RCE Phase I Clinical Trial Data Review Complete 19/07/23 PRICE SENSITIVE download Created with Sketch. 631.65KB Share RCE A$801,604 R&D Rebate Advance Received 12/07/23 PRICE SENSITIVE download Created with Sketch. 223.17KB Share RCE First Cohort Dosed in Rapid Infusion Phase I/II UTI study 10/07/23 PRICE SENSITIVE download Created with Sketch. 266.1KB Share RCE Ethics Approval for Phase I/II UTI Trial Expansion 29/06/23 PRICE SENSITIVE download Created with Sketch. 280.54KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 710.13KB Share RCE Ethics Approval to Start Phase I/II (I.V.) Clinical Trial 17/04/23 PRICE SENSITIVE download Created with Sketch. 258.68KB Share RCE New Family 4 Patent to be Granted for RECCE Anti-Infectives 11/04/23 PRICE SENSITIVE download Created with Sketch. 272.7KB Share RCE Recce Receives Further A$973,144 R&D Advance 04/04/23 PRICE SENSITIVE download Created with Sketch. 220.97KB Share RCE Corporate Presentation - WI Emergence 2023 23/03/23 PRICE SENSITIVE download Created with Sketch. 2.82MB Share RCE Appendix 4D and Interim Financial Report 27/02/23 PRICE SENSITIVE download Created with Sketch. 312KB Share RCE Recce Selects CMAX for Phase I/II UTI Clinical Trial 20/02/23 PRICE SENSITIVE download Created with Sketch. 393.65KB Share RCE Quarterly Activities/Appendix 4C Cash Flow Report 30/01/23 PRICE SENSITIVE download Created with Sketch. 613.04KB Share RCE A$6.21m Received from R&D Rebate Payments 25/01/23 PRICE SENSITIVE download Created with Sketch. 317.75KB Share RCE JP Morgan Healthcare Conference 10/01/23 PRICE SENSITIVE download Created with Sketch. 3.42MB Share RCE Australian Patent to be Granted for RECCE Anti-Infectives 10/01/23 PRICE SENSITIVE download Created with Sketch. 250.74KB Share RCE Anti-Infective Research Unit est. at Murdoch Children's 15/12/22 PRICE SENSITIVE download Created with Sketch. 319.96KB Share RCE Approval to Start Phase I/II Diabetic Foot Ulcer Study 09/12/22 PRICE SENSITIVE download Created with Sketch. 329.13KB Share RCE Trading Halt 07/12/22 PRICE SENSITIVE download Created with Sketch. 643.19KB Share RCE Pause in Trading 07/12/22 PRICE SENSITIVE download Created with Sketch. 113.49KB Share
(20min delay)
